Skip to main content

Effective OA Treatment For Knee Pain Relief: Report On Arthrosamid Released

London-based MSK Doctors (+4403300010048) is now offering Arthrosamid as a long-term treatment for osteoarthritis knee pain and stiffness. A new report explains how this single-injection treatment can provide relief for up to several years, and how patients can book their own appointments.

-- The specialist clinic's new, in-depth care report discusses Arthrosamid, an innovative treatment for osteoarthritis knee pain. Arthrosamid is a single-injection therapy that has been shown to provide long-term pain relief and improve joint function from a single treatment, which is a significant improvement from traditional injection options.

More information about Arthrosamid duration, benefits, and treatments, as well as options for no-referral booking with an MSK Doctors specialist can be found at https://mskdoctors.com/treatments/arthrosamid

Osteoarthritis is a degenerative joint disease that affects millions of people worldwide, and unfortunately, most treatments provide temporary relief at best. Arthrosamid is a unique new treatment option that uses non-biodegradable components, and may be the first injection treatment to offer the potential for long-term relief, without repeated injections, the report suggests.

Arthrosamid is a non-degradable, non-resorbable hydrogel that is injected directly into the knee joint. The hydrogel has the potential to act as a scaffold for the synovial membrane inside the knee, providing mechanical support and cushioning that helps to reduce pain and inflammation and improve joint function.

In clinical studies, Arthrosamid has been shown to provide significant pain relief and improve joint function for up to several years, with no major or long-lasting adverse side effects. The treatment is considered safe and well-tolerated, with the most common side effect being temporary swelling or itching at the injection site, which fades within a few days to a week.

Although Arthrosamid is still considered to be a new treatment, it has been undergoing rigorous clinical studies for more than two decades with no serious complications. Professor Paul Lee, founder of the MSK Doctors clinic, is one of the first UK specialists approved to provide Arthrosamid treatments, and is still one of the most experienced clinicians offering this treatment today.

About MSK Doctors

MSK Doctors is a leading provider of musculoskeletal care in London, with a focus on advanced medical techniques, minimally invasive surgical options, and regenerative care. The clinic offers a wide range of treatments for musculoskeletal conditions, including osteoarthritis, sports injuries, and back pain. MSK Doctors is committed to providing the highest quality care to patients, with no GP referrals or waiting lists required.

Further details about osteoarthritis treatment options, the full report on Arthrosamid, and information about self-booking appointments can be found at https://mskdoctors.com/treatments/arthrosamid

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89150057

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.